Common Stock, Shares, Outstanding of NovaBay Pharmaceuticals, Inc. from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
NovaBay Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • NovaBay Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 6,011,000, a 23% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

NovaBay Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 6,011,000 +1,126,000 +23% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 5,821,000 +4,473,000 +332% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 5,816,000 -26,209,000 -82% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 4,885,000 +4,564,000 +1422% 31 Dec 2024 10-Q 07 Nov 2025 2025 Q3
Q3 2024 4,885,000 -1,644,000 -25% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 1,348,000 -2,866,000 -68% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 32,025,000 +29,990,000 +1474% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 321,000 -1,714,000 -84% 31 Dec 2023 10-K 02 Apr 2025 2024 FY
Q3 2023 6,529,000 -58,459,000 -90% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 4,214,000 -49,299,000 -92% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 2,035,000 -49,384,000 -96% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 2,035,000 +670,000 +49% 31 Dec 2022 10-K 26 Mar 2024 2023 FY
Q3 2022 64,988,000 +20,045,000 +45% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 53,513,000 +8,898,000 +20% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 51,419,000 +9,637,000 +23% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 1,365,000 -40,417,000 -97% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 44,943,000 +3,183,000 +7.6% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 44,615,000 +9,967,000 +29% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 41,782,000 +13,543,000 +48% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 41,782,000 +13,844,000 +50% 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q3 2020 41,760,000 +16,558,000 +66% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 34,648,000 +13,915,000 +67% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 28,239,000 +11,144,000 +65% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 27,938,000 +10,849,000 +63% 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q3 2019 25,202,000 +8,113,000 +47% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 20,733,000 +3,644,000 +21% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 17,095,000 +6,000 +0.04% 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 17,089,000 +1,704,000 +11% 31 Dec 2018 10-K 26 Mar 2020 2019 FY
Q3 2018 17,089,000 +1,728,000 +11% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 17,089,000 +1,780,000 +12% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 17,089,000 +1,801,000 +12% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 15,385,000 +116,000 +0.76% 31 Dec 2017 10-K 29 Mar 2019 2018 FY
Q3 2017 15,361,000 -14,850,146,000 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 15,309,000 +6,152,065 +67% 30 Jun 2017 10-Q 10 Aug 2017 2017 Q2
Q1 2017 15,288,000 +15,282,925 31 Mar 2017 10-Q 11 May 2017 2017 Q1
Q4 2016 15,269,000 +11,783,000 +338% 31 Dec 2016 10-K 21 Mar 2018 2017 FY
Q3 2016 14,865,507,000* +14,790,889,000 30 Sep 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 9,156,935 -64,485,065 -88% 30 Jun 2016 10-Q 11 Aug 2016 2016 Q2
Q1 2016 5,075* -61,107,925 31 Mar 2016 10-Q 12 May 2016 2016 Q1
Q4 2015 3,486,000 +1,420,000 +69% 31 Dec 2015 10-K 23 Mar 2017 2016 FY
Q3 2015 74,618,000 +23,475,000 +46% 30 Sep 2015 10-Q 16 Nov 2015 2015 Q3
Q2 2015 73,642,000 +22,863,000 +45% 30 Jun 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 61,113,000 +10,408,000 +21% 31 Mar 2015 10-Q 14 May 2015 2015 Q1
Q4 2014 2,066,000 -42,558,000 -95% 31 Dec 2014 10-K 04 Mar 2016 2015 FY
Q3 2014 51,143,000 +12,492,000 +32% 30 Sep 2014 10-Q 12 Nov 2014 2014 Q3
Q2 2014 50,779,000 +13,421,000 +36% 30 Jun 2014 10-Q 31 Jul 2014 2014 Q2
Q1 2014 50,705,000 +13,464,000 +36% 31 Mar 2014 10-Q 01 May 2014 2014 Q1
Q4 2013 44,624,000 +7,709,000 +21% 31 Dec 2013 10-K 26 Mar 2015 2014 FY
Q3 2013 38,651,000 +8,904,000 +30% 30 Sep 2013 10-Q 14 Nov 2013 2013 Q3
Q2 2013 37,358,000 +8,490,000 +29% 30 Jun 2013 10-Q 01 Aug 2013 2013 Q2
Q1 2013 37,241,000 +8,414,000 +29% 31 Mar 2013 10-Q 02 May 2013 2013 Q1
Q4 2012 36,915,000 +8,328,000 +29% 31 Dec 2012 10-K 06 Mar 2014 2013 FY
Q3 2012 29,747,000 +1,415,000 +5% 30 Sep 2012 10-Q 01 Nov 2012 2012 Q3
Q2 2012 28,868,000 +5,384,000 +23% 30 Jun 2012 10-Q 09 Aug 2012 2012 Q2
Q1 2012 28,827,000 31 Mar 2012 10-Q 03 May 2012 2012 Q1
Q4 2011 28,587,000 +5,195,000 +22% 31 Dec 2011 10-K 14 Mar 2013 2012 FY
Q3 2011 28,332,000 30 Sep 2011 10-Q 07 Nov 2011 2011 Q3
Q2 2011 23,484,000 30 Jun 2011 10-Q 10 Aug 2011 2011 Q2
Q4 2010 23,392,000 31 Dec 2010 10-K 27 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.